• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期透析和移植患者。

Dialysis and transplant patients in the long term.

作者信息

Bonomini V, Scolari M P, Stefoni S, Vangelista A

出版信息

Ann Ital Med Int. 1993 Apr-Jun;8(2):73-9.

PMID:8353022
Abstract

The history of renal replacement therapy is traced from the early days of dialysis and kidney transplantation through the era of miraculous technology and the alleged certainties of anti-rejection therapy. Attention is focused on the newly found or anomalous biotypes that are common to both dialysis and transplantation. In dialysis not only the patient but also uremia is maintained and either hyper- or hyporeactivity in different biological systems may occur with or without clinical symptoms. In transplantation, while the balance between immunomodulation and immunotolerance is far from ideal, extrarenal complications may occur with an atypical mode of presentation, serious immunological renal lesions may develop asymptomatically and clinical signs of rejection may appear without noticeable laboratory alterations.

摘要

肾脏替代疗法的历史可追溯到透析和肾脏移植的早期,历经了神奇技术时代以及抗排斥疗法所谓的确定性阶段。重点关注透析和移植中常见的新发现或异常生物类型。在透析中,不仅患者得以维持,尿毒症也持续存在,不同生物系统可能出现高反应性或低反应性,且可能伴有或不伴有临床症状。在移植中,尽管免疫调节与免疫耐受之间的平衡远非理想,肾外并发症可能以非典型的表现形式出现,严重的免疫性肾脏病变可能无症状地发展,而排斥反应的临床体征可能在实验室检查无明显改变的情况下出现。

相似文献

1
Dialysis and transplant patients in the long term.长期透析和移植患者。
Ann Ital Med Int. 1993 Apr-Jun;8(2):73-9.
2
Malnutrition in the elderly patient on dialysis.老年透析患者的营养不良
Ren Fail. 2009;31(3):239-45. doi: 10.1080/08860220802669891.
3
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
4
[Renal replacement therapy by hemodialysis: an overview].[血液透析的肾脏替代治疗:概述]
Nephrol Ther. 2009 Jul;5(4):306-12. doi: 10.1016/j.nephro.2009.03.001. Epub 2009 May 28.
5
[Sepsis in patients with terminal chronic kidney failure (a review of the literature)].[终末期慢性肾衰竭患者的脓毒症(文献综述)]
Khirurgiia (Mosk). 1988 Mar(3):131-7.
6
Calorie deficiency in children with uremia: effect upon growth.尿毒症患儿的热量缺乏:对生长的影响。
Pediatrics. 1972 Oct;50(4):590-7.
7
Duration of end-stage renal disease and kidney transplant outcome.终末期肾病的病程与肾移植结果。
Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16.
8
Clinical outcomes in elderly kidney transplant recipients are related to acute rejection episodes rather than pretransplant comorbidity.老年肾移植受者的临床结局与急性排斥反应发作有关,而非移植前的合并症。
Transplantation. 2009 Apr 15;87(7):1045-51. doi: 10.1097/TP.0b013e31819cdddd.
9
[Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].[与保守治疗的慢性终末期肾衰竭患者相比,使用淋巴细胞转化试验(LTT)检测透析患者的细胞免疫]
Z Urol Nephrol. 1986 Apr;79(5):277-86.
10
Interleukin-2 receptor levels in end-stage renal disease and transplant patients.终末期肾病患者和移植患者体内白细胞介素-2受体水平
Transplant Proc. 1990 Aug;22(4):1863-4.